These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33862292)

  • 1. Insight into the drug resistance whole genome of Mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Ali S; Khan AS; Ali A; Khan A; Kaushik AC; Irfan M; Chinnasamy S; Zhang S; Zhang YJ; Cui Z; Wei AJ; Wang Y; Zhao M; Liu K; Wang H; Zeb MT; Wei DQ
    Infect Genet Evol; 2021 Aug; 92():104861. PubMed ID: 33862292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
    Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
    Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversified lineages and drug-resistance profiles of clinical isolates of
    Noorizhab Fakhruzzaman MN; Abidin NZ; Aziz ZA; Lim WF; Richard JJ; Noorliza MN; Hani MH; Norhayati R; Zamzurina AB; Farida Zuraina MY; Hisyam MJ; Teh LK; Norazmi MN; Zaki MS
    Int J Mycobacteriol; 2019; 8(4):320-328. PubMed ID: 31793500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Multi-Drug Resistant
    Ali S; Khan MT; Khan AS; Mohammad N; Khan MM; Ahmad S; Noor S; Jabbar A; Daire C; Hassan F
    Pol J Microbiol; 2020; 69(2):1-5. PubMed ID: 32249555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.
    Katale BZ; Mbelele PM; Lema NA; Campino S; Mshana SE; Rweyemamu MM; Phelan JE; Keyyu JD; Majigo M; Mbugi EV; Dockrell HM; Clark TG; Matee MI; Mpagama S
    BMC Genomics; 2020 Feb; 21(1):174. PubMed ID: 32085703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
    Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of
    He G; Zheng Q; Shi J; Wu L; Huang B; Yang Y
    Microbiol Spectr; 2024 Aug; 12(8):e0334123. PubMed ID: 38904370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan.
    Qadir M; Tahseen S; McHugh TD; Hussain A; Masood F; Ahmed N; Faryal R
    J Infect Chemother; 2021 Nov; 27(11):1578-1583. PubMed ID: 34244055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-Genome Sequencing for Drug Resistance Profile Prediction in
    Gygli SM; Keller PM; Ballif M; Blöchliger N; Hömke R; Reinhard M; Loiseau C; Ritter C; Sander P; Borrell S; Collantes Loo J; Avihingsanon A; Gnokoro J; Yotebieng M; Egger M; Gagneux S; Böttger EC
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
    Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
    J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.
    Sarwer MI; Khan MT; Khurshid S
    J Infect Chemother; 2022 Aug; 28(8):1119-1124. PubMed ID: 35428575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.
    Ezewudo M; Borens A; Chiner-Oms Á; Miotto P; Chindelevitch L; Starks AM; Hanna D; Liwski R; Zignol M; Gilpin C; Niemann S; Kohl TA; Warren RM; Crook D; Gagneux S; Hoffner S; Rodrigues C; Comas I; Engelthaler DM; Alland D; Rigouts L; Lange C; Dheda K; Hasan R; McNerney R; Cirillo DM; Schito M; Rodwell TC; Posey J
    Sci Rep; 2018 Oct; 8(1):15382. PubMed ID: 30337678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of rrs gene mutations in amikacin resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Ahmad K; Ahmad Z; Somayya R; Ali A; Rahat S
    Microb Pathog; 2017 Jul; 108():66-70. PubMed ID: 28479509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
    Sun W; Gui X; Wu Z; Zhang Y; Yan L
    BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar.
    Aung HL; Tun T; Moradigaravand D; Köser CU; Nyunt WW; Aung ST; Lwin T; Thinn KK; Crump JA; Parkhill J; Peacock SJ; Cook GM; Hill PC
    J Glob Antimicrob Resist; 2016 Sep; 6():113-117. PubMed ID: 27530852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru.
    Santos-Lazaro D; Gavilan RG; Solari L; Vigo AN; Puyen ZM
    Sci Rep; 2021 May; 11(1):9493. PubMed ID: 33947918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.